BLAINJECTIONINJECTABLEPriority Review
Approved
Nov 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
3/8 — Basic
Priority Review
Drug data last refreshed 23h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
THYROGEN (thyrotropin alfa) is a recombinant human TSH (thyroid-stimulating hormone) administered by injection to stimulate thyroid hormone production. It is used primarily in thyroid cancer patients to enhance radioactive iodine uptake during diagnostic imaging and therapeutic procedures, eliminating the need for thyroid hormone withdrawal. The drug mimics the body's natural TSH to activate thyroid tissue without the clinical side effects of endogenous TSH elevation.
$0.398MPart D
LOE ApproachingProduct approaching loss of exclusivity with modest Part D spending ($398K) and low claim volume (98 claims in 2023), signaling a mature, niche therapeutic with a small commercial footprint and likely minimal team expansion.
Mechanism of Action
Pharmacologic Class:
Thyroid Stimulating Hormone
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.
Started May 2006
61 enrolled
Differentiated Thyroid Cancer
Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone
Started Jun 2005
46 enrolled
Healthy
Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration
Started Dec 2001
63 enrolled
Thyroid Neoplasms
Career Relevance
Worked on THYROGEN at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.